Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000290928 | SCV000408811 | uncertain significance | Dyggve-Melchior-Clausen syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000329327 | SCV000408812 | uncertain significance | Smith-McCort dysplasia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001753786 | SCV001986513 | uncertain significance | not provided | 2020-06-15 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001753786 | SCV002397273 | likely benign | not provided | 2024-09-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003243082 | SCV003941644 | likely benign | Inborn genetic diseases | 2023-05-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |